MMSI · Merit Medical Systems, Inc.
$73.11
+0.00% last session
End-of-day data · updated 2026-07-25
Market cap
$4B
Enterprise value
$5B
Trailing P/E
32.0
Forward P/E
16.9
Dividend yield
—
Beta
0.51
Avg volume
1M
Employees
8K
2D change
1.66%
5D change
-1.13%
10D change
1.75%
30D change
4.93%
60D change
15.19%
MTD change
7.01%
YTD change
-15.68%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — MMSI
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-05-01
Latest call per bank · past 12 months
JP Morgan
Overweight$77.00
+5.3% vs priceWells Fargo
Equal-Weight$74.00
+1.2% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-05-01 | Canaccord Genuity | Maintains | Buy | $90.00 → $85.00 |
| 2026-05-01 | JP Morgan | Maintains | Overweight | $95.00 → $77.00 |
| 2026-05-01 | Wells Fargo | Maintains | Equal-Weight | $78.00 → $74.00 |
| 2026-05-01 | Needham | Maintains | Buy | $101 → $90.00 |
| 2026-04-20 | Barrington Research | Maintains | Outperform | $109 → $107 |
| 2026-04-17 | Piper Sandler | Maintains | Overweight | $106 → $96.00 |
| 2026-04-07 | Canaccord Genuity | Maintains | Buy | $99.00 → $90.00 |
| 2026-04-01 | Needham | Reiterates | Buy | $101 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-23
- RSI (14): RSI is 57 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 8.2% above the 50-day MA ($67.60).
- Price vs 200-day MA: Trading 3.9% below the 200-day MA ($76.08).
- MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- MACD (12,26,9): MACD histogram is negative (-0.11) — short-term momentum is fading.
- 52-week range: Price sits between the 52-week low ($60.31) and high ($93.18).
MMSI Price Chart
Loading chart for MMSI…
Fundamentals
About Merit Medical Systems, Inc.
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.
More in Medical Instruments & Supplies
ISRG
Intuitive Surgical, Inc.
$121B -40.4% YTD
MDLN
Medline Inc.
$69B -7.7% YTD
BDX
Becton, Dickinson and Company
$43B 3.9% YTD
ALC
Alcon Inc.
$33B -13.4% YTD
RMD
ResMed Inc.
$28B -18.5% YTD
WST
West Pharmaceutical Services, I
$23B 19.5% YTD
COO
The Cooper Companies, Inc.
$14B -14.2% YTD
SOLV
Solventum Corporation
$14B -1.6% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.